Dr. Davies has extensive synthetic organic chemistry experience through both her PhD studies and her postdoctoral research at California Institute of Technology, focusing on the synthesis of complex natural products and the discovery of new reaction methodologies.
Prior to joining Goodwin, Dr. Davies spent 13 years as a medicinal chemist at a mid-size Boston pharmaceutical company. She has led drug discovery efforts on two early stage antiviral projects and has worked as a drug discovery scientist on projects in diverse therapeutic areas such as oncology, antibacterials and CNS.
Dr. Davies is an author on seven peer-reviewed scientific papers and 13 granted U.S. patents.